EDAP TMS SA (EDAP)
3.49
-0.10
(-2.79%)
USD |
NASDAQ |
Apr 17, 16:00
3.45
-0.04
(-1.15%)
After-Hours: 20:00
EDAP TMS SG&A Expense (Quarterly) : 13.22M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| DBV Technologies SA | 12.79M |
| Cellectis SA | 4.798M |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 4.191M |
| Akari Therapeutics Plc | 2.138M |